Ischemic stroke after AstraZeneca (Covid-19) vaccination

References

1. 1.↵
   1. Greinacher, A.,
   2. Thiele, T.,
   3. Warkentin, T. E.,
   4. Weisser, K.,
   5. Kyrle, P. A., &
   6. Eichinger, S.

   Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 2021; 384: 2092–2101.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Østergaard SD,
   2. Schmidt M,
   3. Horváth-Puhó E,
   4. Thomsen RW,
   5. Sørensen HT.

   Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence? Lancet 2021; 397: 1441–1443.

   OpenUrlPubMed
3. 3.↵
   1. Wise J.

   Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. BMJ 2021; 372: n699.

   OpenUrlFREE Full Text
4. 4.↵
   European Medicines Agency. Signal assessment report on embolic and thrombotic events (SMQ) with COVID-19 Vaccine (ChAdOx1-S [recombinant]) – COVID-19 Vaccine AstraZeneca (Other viral vaccines). [Updated 2021; Accessed 2021 April 21]. Available from: https://www.ema.europa.eu/en/documents/prac-recommendation/signal-assessment-report-embolic-thrombotic-events-smq-covid-19-vaccine-chadox1-s-recombinant-covid_en.pdf
5. 5.↵
   1. Morassi M,
   2. Bagatto D,
   3. Cobelli M,
   4. D’Agostini S,
   5. Gigli GL,
   6. Bnà C,
   7. Vogrig A.

   Stroke in patients with SARS-CoV-2 infection: case series. J Neurol 2020; 267: 2185–2192.

   OpenUrlPubMed
6. 6.↵
   1. Thoon KC,
   2. Chan DW.

   Childhood stroke after influenza vaccination. SAGE 2012; 21: 297–300.

   OpenUrl
7. 7.↵
   1. Schultz NH,
   2. Sørvoll IH,
   3. Michelsen AE,
   4. Munthe LA,
   5. Lund-Johansen F,
   6. Ahlen MT,
   7. Wiedmann M,
   8. Aamodt AH,
   9. Skattør TH,
   10. Tjønnfjord GE,
   11. Holme PA.

   Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med 2021; 384: 2124–2130.

   OpenUrlPubMed
8. 8.↵
   1. Greinacher A,
   2. Thiele T,
   3. Warkentin TE,
   4. Weisser K,
   5. Kyrle PA,
   6. Eichinger S.

   Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 2021; 384: 2092–2101.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Muir KL,
   2. Kallam A,
   3. Koepsell SA,
   4. Gundabolu K.

   Thrombotic thrombocytopenia after Ad26. COV2. S vaccination. N Engl J Med 2021; 384: 1964–1965.

   OpenUrl
10. 10.↵
    European Medicines Agency. COVID19 vaccine AstraZeneca benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets. [Updated 2021 March 18. Accessed 2021 April 23]. Available from: https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots